Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial
Open Access
- 31 August 2010
- journal article
- research article
- Published by Wiley in International Journal of Andrology
- Vol. 33 (5), 736-744
- https://doi.org/10.1111/j.1365-2605.2009.01017.x
Abstract
The effects of weight loss on erectile function and hormones have not been well studied. The aim of this study was to measure the degree to which sexual function and in particular erectile function and hormonal environment change after substantial weight loss, surgically and non‐surgically induced in the morbidly obese male in a prospective randomized long‐term controlled trial. Furthermore, how surgery makes a difference when treating morbidly obese men was envisaged in this context. We prospectively studied 20 morbidly obese men for 24 months, divided into two groups: group A included 10 patients who underwent life style modifications (exercise and diet) for 4 months and subsequently gastric bypass, and another 10 patients in group B were kept on weekly follow‐up. None of the men were taking phosphodiesterase type‐5 inhibitors. All patients underwent International Index of Erectile Function (IIEF)‐5 questionnaire, serum oestradiol, prolactin (PRL), luteinizing (LH) and follicle‐stimulating (FSH) hormones, free and total testosterone (FT and TT) at baseline (time 0), surgery – 4 months latter baseline (time 1) and final evaluation – 24 months (time 2). From times 0 to 1, group A presented a mean body mass index (BMI) reduction of 12.6 (p < 0.0001), whereas group B, 2.1 (p > 0.05). The BMI reductions between times 0 and 2 were 24.7 (p < 0.0001) and 0.7 (p > 0.05) for groups A and B respectively. BMI average between the two groups was similar at time 0 (p = 0.2142), and different at times 1 (p = 0.0033) and 2 (p < 0.0006). Increase in IIEF‐5 score (p = 0.0469), TT (p = 0.0349) and FSH levels (p = 0.0025), and reduction in PRL level (p < 0.0001) were observed in group A from times 0 to 2 and 1 to 2. There were no changes from times 0 to 1. Comparing groups A and B at time 2, IIEF‐5, TT and FT increased significantly in group A (p = 0.0224, 0.0043 and 0.0149 respectively). Surgery‐induced weight loss increased erectile function quality measured by IIEF‐5 questionnaire, increased TT, FT and FSH and reduced PRL levels. The hormonal impact verified could justify the improvement in erectile function. Lifestyle modifications impacted BMI without hormonal or sexual impact in morbidly obese. New studies are warranted in the field to support our data.Keywords
This publication has 57 references indexed in Scilit:
- Effect of Roux-en-Y Gastric Bypass Surgery on the Sex Steroids and Quality of Life in Obese MenJournal of Clinical Endocrinology & Metabolism, 2009
- Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US menCancer Causes & Control, 2009
- Statin Therapy Is Associated With Lower Total but Not Bioavailable or Free Testosterone in Men With Type 2 DiabetesDiabetes Care, 2008
- Low Levels of Androgens in Men with Erectile Dysfunction and ObesityThe Journal of Sexual Medicine, 2008
- Long-Term Mortality after Gastric Bypass SurgeryThe New England Journal of Medicine, 2007
- Prevalence of Overweight and Obesity in the United States, 1999-2004Published by American Medical Association (AMA) ,2006
- HYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPYJournal of Urology, 2005
- Endocrine Aspects of Sexual Dysfunction in MenThe Journal of Sexual Medicine, 2004
- Adipose Tissue Intracrinology: Potential Importance of Local Androgen/Estrogen Metabolism in the Regulation of AdiposityHormone and Metabolic Research, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001